A Complement Inhibitor for Dry Macular Degeneration

The April 3 issue of The Medical Letter includes an article on the first treatment ever approved by the FDA for use in patients with dry age-related macular degeneration (AMD). More specifically, pegcetacoplan (Syfovre) was approved for treatment of geographic atrophy, which is a late stage of dry AMD. AMD is common; according to the […]